Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)
Recent comments
1 week 1 day ago
1 week 6 days ago
11 weeks 6 days ago
15 weeks 6 days ago
17 weeks 8 hours ago
17 weeks 11 hours ago
38 weeks 23 hours ago
42 weeks 1 day ago
43 weeks 6 days ago
43 weeks 6 days ago